Literature DB >> 22162567

Adiponectin: a risk biomarker and attractive target for chemoprevention.

Carol J Fabian.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22162567     DOI: 10.1200/JCO.2011.38.5500

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

Review 1.  Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis.

Authors:  Debora Macis; Aliana Guerrieri-Gonzaga; Sara Gandini
Journal:  Int J Epidemiol       Date:  2014-04-15       Impact factor: 7.196

Review 2.  The role of adiponectin in cancer: a review of current evidence.

Authors:  Maria Dalamaga; Kalliope N Diakopoulos; Christos S Mantzoros
Journal:  Endocr Rev       Date:  2012-04-30       Impact factor: 19.871

3.  Obesity, insulin resistance, adipocytokines and breast cancer: New biomarkers and attractive therapeutic targets.

Authors:  Maria Dalamaga
Journal:  World J Exp Med       Date:  2013-08-20

Review 4.  Metabolic syndrome in breast cancer.

Authors:  Víctor Manuel Vargas-Hernández; Vm Vargas-Aguilar; Mario Adanm Moreno-Eutimio; Gustavo Acosta-Altamirano; Jm Tovar-Rodriguez
Journal:  Gland Surg       Date:  2013-05

Review 5.  Leptin and adiponectin: emerging therapeutic targets in breast cancer.

Authors:  Eva Surmacz
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-10-18       Impact factor: 2.673

Review 6.  Obesity, metabolism and the microenvironment: Links to cancer.

Authors:  Sneha Sundaram; Amy R Johnson; Liza Makowski
Journal:  J Carcinog       Date:  2013-10-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.